Marketresearchnews

Friday, 20 March 2020

Clinical Nutrition Market 2019 Global– Key Players, Size, Trends, Growth- Analysis To 2023

Market Scenario

With the increasing aged population, the clinical nutrition spends are estimated to increase in the future. Due to the weak digestive framework at an old age, it becomes difficult for human body to digest all the required nutrients, rom food. Among aged population, the loss of appetite is considered a major issue; due to which, the elderly population does not get necessary amount of nutrients.

Therefore to get sufficient supplements, the confidence of the aged population towards clinical nutrition support, is growing. The global clinical nutrition market is going up because of high birth rate, raise in the number of victims receiving malnutrition treatment, and high number of premature births.

Study Objectives of Clinical Nutrition

To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Global Clinical Nutrition Market

To provide insights about factors affecting the market growth

To Analyze the Clinical Nutrition Market based on various factors- price analysis, supply chain analysis, porter’s five force analysis etc.

To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW)

To provide country level analysis of the market with respect to the current market size and future prospective

To provide country level analysis of the market for segment by product types and their sub -segments

To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Clinical Nutrition Market

Key Findings

Asia-Pacific dominated the global clinical nutrition market in 2014; however it is expected to grow at a CAGR of XX% during 2016 – 2027.

The infant nutrition segment hold the largest share, with $XX billion value of the total market in 2014; while it is expected to reach $XX billion in 2027, at a CAGR of XX% for the period 2016-2027.

The milk-based infant nutrition segments hold the largest share, with $XX billion value, of the total market in 2014; while it is expected to reach $XX billion in 2027, at a CAGR of XX% for the period 2016 – 2027.

Key Players

The key players that are involved in Global Clinical Nutrition market are Baxter International, Inc, Abbott Laboratories, B. Braun Melsungen AG, Nestlé S.A, GroupeDanone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira, Inc, Perrigo Company Plc and among others.

Segments
Segmentation by Product

On the basis of product the market is segmented into:

Infant Nutrition (Milk Based, Soy Based, Organic, Others and Probiotic/Prebiotic)

Enteral Nutrition (Standard and For Chronic Illness)

Parenteral Nutrition

The report for Clinical Nutrition Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday, 18 March 2020

Neurostimulation Devices Industry Overview By Growth Factors, Product Chain Value, Competitors Analysis And Forecast 2023

Bioinformatics Market Information, by Application (genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics and others), by Technology and Services (data warehousing, sequence analysis, sequence manipulation and others), by Sector (medical bioinformatics, animal bioinformatics, agriculture bioinformatics and others) - Forecast to 2022

Market scenario:

The Global Bioinformatics Market is expected to exhibit a CAGR of 19.8% over the forecast period from 2016 to 2022, according to a new research report from Market Research Future (MRFR). The global bioinformatics trends and industry is mainly driven by the growing demand in developing countries in enhancing their healthcare sector and making advanced healthcare modalities available to patients.

The growing demand for electronic healthcare data storage is likely to be a major driver for the global bioinformatics market. The reliance on manual and paper-based documentation of healthcare procedures has resulted in unmanageable volumes of healthcare information, which can make it difficult to locate individual patients and their medical history. Electronic healthcare records, which are but the first step of the bioinformatics market, have already become widely popular in developed countries due to the benefits they present in terms of consistent data storage over the long term and ease in acquiring specific details at any given time. The growing demand for e-prescriptions and online pharmacies is likely to further the cause of the bioinformatics market over the forecast period, as strong bioinformatics networks are needed to operate and manage e-prescriptions and the related documentation.

The growing demand for strong data storage facilities in medical research is also likely to be a major driver for the global bioinformatics market. Bioinformatics plays a key role in genetic studies, in which it helps track details regarding multiple genes and their multifarious associations with the indicators being studied in the respective trial. The growing dependence on genetic studies in cancer research is likely to be a major driver for the global bioinformatics market over the forecast period, as cancer research has received strong government backing across the world. Other medical research applications are also likely to make use of bioinformatics systems on a large scale in the coming years, leading to steady growth of the global bioinformatics market over the forecast period.

Study Objectives of Bioinformatics Market:

To provide detail analysis of the market structure along with forecast for the next 7 years about various segments and sub-segments of the global bioinformatics market.
To provide insights about factors affecting the market growth.
To analyze the market based on price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospective.
To provide country level analysis of the market for segments by drug application, by technology, by sector and services and its sub-segments.
To provide overview about key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Bioinformatics market.

Intended Audience

Bioinformatics service providers
Bioinformatics manufacturers
Research and development (R&D) companies
Government research laboratories
Government and independent regulatory authorities

Segmentation:

The global bioinformatics market is segmented on the basis of application, service, sector, and region in the MRFR report in order to provide a comprehensive coverage of all important factors related to the market’s growth prospects over the forecast period.

The bioinformatics market has been segmented on the basis of application into genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences, and others. Increasing interest in genetic studies is likely to be a major driver for the global bioinformatics market over the forecast period.

On the basis of services and technology, the global bioinformatics market is segmented into data warehousing, sequence analysis, sequence manipulation, and others.

Key Players for Bioinformatics Market:

Agilent Technologies,
Illumina, Inc.,
QIAGEN N. V, and Thermo Fisher Scientific Inc.,
Dassault Systèmes,
QIAGEN and others.

Regional Analysis:

The global bioinformatics market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The global bioinformatics market is dominated by the Americas and Europe in terms of region due to the presence of strong telecommunications infrastructure in these regions to support advanced bioinformatics processes. The presence of a strong wireless internet and other telecommunication features is crucial for a bioinformatics system to function productively. This has actually been one of the key factors that has held back the bioinformatics market in underdeveloped regions.

In April 2019, researchers from UCLA announced a plan to develop a system that would allow scientists in developing countries to use cloud computing and big data analytics to accelerate the development of the bioinformatics field in their own countries. Efforts such as these are the result of the growing awareness of the disparity in terms of telecommunications infrastructure between developed and developing countries.

Asia Pacific is likely to exhibit the fastest growth over the forecast period due to the increasing efforts from governments in the region to incorporate powerful bioinformatics programs into the day-to-day functioning of their country’s healthcare sector.

Browse more Life Sciences Reports @ https://www.marketresearchfuture.com/categories/life-sciences-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Neurostimulation Devices Market Trend, Industry Overview, Competitive Analysis And Foreseen By 2023

Market Scenario:

Neurostimulation is a modulation of the nervous system’s activity. It is deliberately carried out by using invasive and non-invasive techniques. Implantable stimulation devices are most commonly used in the treatment of the neurological conditions such as epilepsy, Parkinson’s disease, dystonia, tremors, depression, obsessive compulsive disorder, diabetic neuropathy and few other conditions. Increasing cases of the neurological disorders such as chronic pain and depression high adoption of the Neurostimulation therapy are likely to improve the market of Neurostimulation devices. Globally, this Neurostimulation Devices Market Size is growing steadily and it is anticipated to show an exponential growth reaching approximately $11.5 billion in 2022

Segments:

Global Neurostimulation devices market has been segmented on the basis of type which comprises implantable devices, and external devices. Implantable devices include deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, gastric electric stimulators, cochlear implants, and vagus nerve stimulators; whereas external devices include transcutaneous electrical nerve stimulator, and transcranial magnetic stimulator. On the basis of application, the market is segmented into dystonia, epilepsy, Parkinson's disease, depression, gastroparesis, pain management, tremors, urinary and fecal incontinence, and others. On the basis of end user, market is segmented into hospitals/clinics, cognitive care centers, research institutes and others.

Regional Analysis of Neurostimulation devices Market:

Considering the global scenario of the market, Americas region is believed to be the largest market for Neurostimulation devices. Moreover, the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Neurostimulation devices segment during the forecast period. Middle East & Africa region are likely to have a limited but steady growth in the market.

Key Players for Neurostimulation devices Market:

Some of the key players in this market are: Autonomic Technologies, Boston Scientific, ElectroCore, ImThera Medical, Inspire Medical Systems, LivaNova (Cyberonics), Medtronic, NeuroMetrix, NeuroPace, Neuros Medical, NeuroSigma, Nevro Corporation, SPR Therapeutics, St.Jude Medical, Synapse Biomedical, and others.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global Neurostimulation Devices market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial blockage, and coronary artery disease among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way.

According to the data published by the Department of Health, New York in May 2018, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. Besides this, the high medical awareness among American population, high disposable income, presence of the top medical device manufacturers in the region are some of the many factors that drive the growth of the Neurostimulation Devices market in this region.

Europe is expected to hold the second largest market share in the global Neurostimulation Devices market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the Neurostimulation Devices market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the Neurostimulation Devices market during the forecast period.

Browse more Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Regenerative Medicine Market 2019 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

Market Scenario:

The Global Regenerative Medicine Market is growing steadily. Factors that influence the regenerative medicine market are increasing advancement in healthcare technology, increasing advance technology in regenerative medicine market, increasing prevalence of chronic diseases, increasing growth in stem cell technology and others. Globally regenerative medicine market size is expected to grow at the rate of about 25.4% from 2016 to 2022.

Investments are likely to flow towards the regenerative medicine market over the next couple of years. In addition, the support extended by the government for drug development is poised to revolutionize the future trajectory of the global market. It is also likely to benefit from technological advancements in the market.

Stem cell technology is gaining traction in the healthcare sector. Its accelerated adoption in the field of medical science is also anticipated to have a favorable impact on the expansion of the regenerative medicine market. The players of the market are forecasted to capitalize on the gap prevailing between the demand and supply for organs. However, factors such as stringent regulations, and the high cost of the treatment are expected to check the proliferation of the regenerative medicine market through the projection period.

Market Segmentation:

on the basis of material, the regenerative medicine market has been segmented into synthetic materials, genetically engineered materials, pharmaceuticals, biologically derived materials, and others.

On the basis of therapy, the global regenerative medicine market has been segmented into stem cell biology, cellular therapy, tissue engineering, and others.

On the basis of application, the regenerative medicine market has been segmented into cord blood, oncology, urology, orthopedics, neurology, dermatology, cardiovascular, orthopedic and others.

Competitive Dashboard:

Some of the key players profiled in the report are Cook Biotech, Organogenesis, Stryker and RTI surgical, Baxter International, Inc., Osiris Therapeutics, CryoLife, Sanofi, LifeSciences, Advanced Cell Technology, BioMimetic Therapeutics, LifeCell Kinetic Concepts, StemCellsInc, and Medtronic.

Regional Analysis:

The global regenerative medicine market, by region, has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is currently holding the largest share of the market, accounting for 44% share. It is expected to grow significantly at a CAGR of 22.3% during the forecast period. The factors such as developments in healthcare technology, presence of advanced healthcare infrastructure, increasing burden of chronic diseases, etc.

Europe has gained control over the second-largest share of the market. It is expected to strike a high CAGR of 22.5% over the assessment period. The availability of funds coupled with the government’s support is likely to accelerate research & development activities. This, in turn, is prognosticated to boost the growth trajectory of the regional regenerative medicine market in the upcoming years.

Asia Pacific is a highly lucrative market and is expected to remain so across the review period. The rapid developments in the healthcare sector and growing patient pool are anticipated to drive the expansion of the regenerative medicine market in the region. It is estimated to mark a relatively higher CAGR and emerge as the fastest growing regional market in the foreseeable future.

Industry News:

In November 2018, 3D.FAB, a French additive manufacturing platform, has announced that it is working on the development of a “living bandage” using direct additive manufacturing and 3D bioprinting for treating damaged tissues.

In December 2018, Food and Drug Administration has sent Genetech, a CA-based biotechnology subsidiary of Roche, and other firms and providers offering stem cell treatments warning letters to notify about agency's regenerative medicine policy framework.

Browse more Pharmaceutical Reports @ https://www.marketresearchfuture.com/categories/pharmaceutical-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cleanroom Technology Industry Growth, Trends And Forecast Till 2023 By Marketresearchfuture.Com

Market Scenario:

The growing biotechnology sector is likely to be a major driver for the global cleanroom technology market over the forecast period. Biotechnology research and product development require a complete absence of potential contaminants, as even the smallest presence of contaminants can ruin the results of the research or product development efforts. The growing life sciences sector has driven investment in the biotechnology sector in recent years, as disease treatment and other application avenues have come in sharp focus. Increasing government support to the life sciences sector is likely to be the major driver for the global cleanroom technology market over the forecast period.

Cleanroom is basically a controlled environment which has low level of pollutants such as air-born microbes and particles, dust, aerosols which contaminate the surrounding area. Cleanroom technology is used by nearly all the industries in order to avoid the adverse effects caused by the air pollutants and small particles in the manufacturing process of a product. Globally the market for cleanroom technology is growing rapidly. Global cleanroom technology market is expected to show an exponential growth and would reach approximately $4 Billion in 2022.

The increasing pharmaceutical industry is also likely to be a major contributor to the global cleanroom technology market. Increasing efforts to come up with more efficient and effective pharmaceutical formulations are likely to lead to increasing demand from the cleanroom technology market over the forecast period. Other industries are also making increasing use of cleanroom technology in order to enhance the manufacturing process, which is likely to drive the global cleanroom technology market at a strong growth rate over the forecast period.

Key Players

Alpiq Group,
Ardmac Ltd,
Camfil,
Clean Air Products,
Helapet Limited,
M+W Group GmbH,
Nicomac Srl,
Royal Imtech N.V.,
Simplex Isolation Systems,
Taikisha Ltd. and others.

Segmentation:

The global cleanroom technology market is segmented on the basis of equipment, consumable, end user, and region.

The cleanroom technology market has been segmented on the basis of equipment into laminar air flow, HEPA filters, cleanroom air showers, cleanroom filters, desiccator cabinets, particle counters, cleanroom pass through systems, environmental monitoring system, and others.

On the basis of consumables, the market is segmented into head-caps, gloves, face masks, lab suits, footwear, wipes, swabs, disinfectants, and others.

On the basis of end user, the cleanroom technology market is segmented into pharmaceutical industry, biotechnology industry, research laboratories, and others.

Study Objectives of Cleanroom Technology Market:

To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the cleanroom technology market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by equipment, by consumables, by industry and its sub-segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global cleanroom technology market.

Regional Analysis

Globally Americas is the largest market for cleanroom technology. Europe is the second-largest market. Furthermore Asia-Pacific market is expected to be the fastest growing market for cleanroom technology.

The report for cleanroom technology market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse more Healthcare IT Reports @ https://www.marketresearchfuture.com/categories/healthcare-it-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Sepsis Diagnostics Market 2019 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

Global Sepsis Diagnostics Market Information, By Technology (Molecular Diagnostics, Biomarkers, Immunoassays and others), By Type of Product (Kits, Instruments, Blood Culture Media and others), By End Users (Pathology Laboratories, Specialty Clinics, Hospitals, Diagnostic Centers and others)- Forecast Till 2022

Global Sepsis Diagnostics Market 2019 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis.

Market Scenario:

An expert on premium research reports, Market Research Future has added a report titled "Global Sepsis Diagnostics Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Sepsis is a type of life-threatening organ dysfunction arises when the body's response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds. It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis, which is one of the driving factor for sepsis diagnostics market.

The global market for sepsis diagnostics market size is expected to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.

Competitive Analysis

bioMérieux, Inc.
EKF Diagnostics
Immunexpress
T2 Biosystems, Inc.
Becton
Dickinson and Company
Axis-Shield Diagnostics Ltd.
Cube Dx GmbH
Sandstone Diagnostics, Inc.

Study Objectives of Global Sepsis Diagnostics Market:

To provide detail analysis of the market structure along with forecast for the next 7 years of various segments and sub-segments of the global sepsis diagnostics market.
To provide insights about factors affecting the market growth.
To analyze the market based on various factors which includes price analysis, supply chain analysis, Porters Five Force Analysis etc.
To offer past as well as estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries; these includes Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and estimated future growth of the market.
To give country level analysis of the market’s segments which includes by technology, by type of product, by end users and other sub segments.
To provide overview about key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape for the market.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, along with research and developments that is taking place globally.

Segmental Analysis

Global sepsis diagnostics market has been segmented on the basis of technology which comprises molecular diagnostics, biomarkers, immunoassays and others. On the basis of type of product product types; the market is segmented into kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.

Regional Analysis

Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.

Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.

The report of global sepsis diagnostics market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and projected future market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. Along with all these detail information and strategies about top key players in the industry is also given. Further a broad study of different markets segments and regions is also provided.

Industry Updates:

Dec 2018 Beckman Coulter, which is an international leader in the clinical diagnostics industry has announced that it is joining forces with Sepsis Alliance, the nation's leading sepsis organization, to support the Sepsis Coordinator Network. The pioneering online, peer-to-peer alliance for healthcare professionals, the Sepsis Coordinator Network is dedicated to saving lives by advancing patient results.

May 2018 Mobidiag, a Finnish firm, has obtained funding to creäte a rapid molecular sepsis assay on its Novodiag system. The fresh funding comprises of a €1.5 million ($1.74 million) loan for the first year of the project provided by Business Finland, a funding agency previously known as Tekes.

Browse more Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

International North America Microarray Market And Prominence 2023 On Consumer Needs, Revenue, Pricing Strategy And Growth Rate

Market Scenario:North America the market for Microarray is increasing rapidly. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development. North American market for Microarray is expected to grow at the rate of about 4.0% from 2016 to 2027.

Key Finding

The North America microarray market is expected to reach $1,635.4 billion by 2027.
Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market.
U.S. holds the largest market share of North America Tissue Microarray market and is anticipated to reach $364.2 million by the end of 2027.
Immunohistochemistry segment holds the largest market share of 47.5% in 2015.

Segments:
North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray. On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others. On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.

Regional Analysis of North America Microarray Market:
In North America, U.S. is the largest market for Tissue Microarray. Canada is the second-largest market and is expected to be fastest growing market for Tissue Microarray in North America.

Key Players for North America Microarray Market:
Some of the key players in this North America Microarray Market are: ABCAM, ASTERAND BIOSCIENCE, IHC WORLD LLC, NOVUS BIOLOGICALS LLC (ACQUIRED BY BIO-TECHNE), ORIGENE TECHNOLOGIES INC, PANTOMICS, INC, PROTEIN BIOTECHNOLOGIES INC, US BIOMAX, INC., US BIOUPTON INT, VITROVIVO BIOTECH, LLC and others.

Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com